Effects of intracerebroventricular galanin or a galanin receptor 2/3 agonist on the lesion induced by transient occlusion of the middle cerebral artery in female rats

[1]  N. Kerr,et al.  Galanin acts as a trophic factor to the central and peripheral nervous systems. , 2010, Experientia supplementum.

[2]  J. Järv,et al.  A novel GalR2-specific peptide agonist , 2009, Neuropeptides.

[3]  T. Bártfai,et al.  Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  N. Kerr,et al.  Galanin – 25 years with a multitalented neuropeptide , 2008, Cellular and Molecular Life Sciences.

[5]  D. Wynick,et al.  Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage , 2007, Journal of neurochemistry.

[6]  G. Bernardi,et al.  Specific expression of galanin in the peri-infarct zone after permanent focal cerebral ischemia in the rat , 2006, Regulatory Peptides.

[7]  T. Hökfelt,et al.  The galanin‐R2 agonist AR‐M1896 reduces glutamate toxicity in primary neural hippocampal cells , 2005, Journal of neurochemistry.

[8]  Annette Theodorsson,et al.  Estradiol increases brain lesions in the cortex and lateral striatum after transient occlusion of the middle cerebral artery in rats: No effect of ischemia on galanin in the stroke area but decreased levels in the hippocampus , 2005, Peptides.

[9]  T. Bártfai,et al.  Galanin (2–11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes , 2005, Neuropeptides.

[10]  E. Theodorsson,et al.  Modern anesthesia and peroperative monitoring methods reduce per- and postoperative mortality during transient occlusion of the middle cerebral artery in rats. , 2005, Brain research. Brain research protocols.

[11]  I. Hwang,et al.  Ischemia-related changes in galanin expression in the dentate hilar region after transient forebrain ischemia in gerbils. , 2005, Experimental animals.

[12]  T. Hökfelt,et al.  A Galanin Receptor Subtype 1 Specific Agonist , 2005, International Journal of Peptide Research and Therapeutics.

[13]  Seon-Gil Do,et al.  Expression and changes of galanin in neurons and microglia in the hippocampus after transient forebrain ischemia in gerbils , 2004, Brain Research.

[14]  Barnaby C. Marsh,et al.  Galanin acts as a neuroprotective factor to the hippocampus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Hökfelt,et al.  Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy , 1996, Experimental Brain Research.

[16]  T. Hökfelt,et al.  Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23) , 2003, Neurobiology of Disease.

[17]  J. Shine,et al.  The Second Galanin Receptor GalR2 Plays a Key Role in Neurite Outgrowth from Adult Sensory Neurons , 2003, The Journal of Neuroscience.

[18]  J. Franklin,et al.  Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia , 2002, Journal of neurochemistry.

[19]  F. Mennicken,et al.  Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system , 2002, Journal of Chemical Neuroanatomy.

[20]  N. Cairns,et al.  The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. , 2002, Brain research. Molecular brain research.

[21]  T. Hökfelt,et al.  Effects of galanin receptor agonists on locus coeruleus neurons , 2001, Brain Research.

[22]  T. Hökfelt,et al.  Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: Selective actions via GalR1 and GalR2 receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  U. Lendahl,et al.  Can galanin also be considered as growth-associated protein 3.2? , 2001 .

[24]  V. King,et al.  Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Kehr,et al.  Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Hökfelt,et al.  Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein — initial observations , 2000, Neuroscience.

[27]  T. Branchek,et al.  Galanin receptor subtypes. , 2000, Trends in pharmacological sciences.

[28]  S. McMahon,et al.  Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury , 2000, The European journal of neuroscience.

[29]  E. T. O. Rugarn.  Radioimmunoassay for rat galanin: immunochemical and chromatographic characterization of immunoreactivity in tissue extracts , 2000, Scandinavian journal of clinical and laboratory investigation.

[30]  J. Krause,et al.  Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues , 1999, Neuroscience.

[31]  C. Wahlestedt,et al.  Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: Distinct distribution from GALR1 , 1999, The Journal of comparative neurology.

[32]  K. A. Jones,et al.  Cloned Human and Rat Galanin GALR3 Receptors , 1998, The Journal of Biological Chemistry.

[33]  T. Hökfelt,et al.  Galanin/GMAP‐ and NPY‐like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin‐R1 and ‐R2 receptors , 1998, The Journal of comparative neurology.

[34]  M. Bayne,et al.  Cloning and Expressional Characterization of a Novel Galanin Receptor , 1997, The Journal of Biological Chemistry.

[35]  R. Paczynski,et al.  Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. , 1996, Stroke.

[36]  J. Crawley,et al.  Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. , 1996, Brain research. Molecular brain research.

[37]  R. Mohney,et al.  Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. , 1996, Perspectives on developmental neurobiology.

[38]  S. Grillner,et al.  Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice , 1995, Neuroscience.

[39]  R. Rhoades,et al.  Evidence for survival of the central arbors of trigeminal primary afferents after peripheral neonatal axotomy: Experiments with galanin immunocytochemistry and Di‐I labelling , 1994, The Journal of comparative neurology.

[40]  J. Mayaux,et al.  Molecular cloning of a functional human galanin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Meister,et al.  Reorganization of neural peptidergic systems in the median eminence after hypophysectomy , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  M. Palkovits,et al.  Selective Up-Regulation of Neuropeptide Synthesis by Blocking the Neuronal Activity: Galanin Expression in Septohippocampal Neurons , 1994, Experimental Neurology.

[43]  R. Hamm,et al.  Protective effect of galanin on behavioral deficits in experimental traumatic brain injury. , 1994, Journal of neurotrauma.

[44]  P. Brûlet,et al.  Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons , 1993, Neuron.

[45]  W. Benzing,et al.  Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. , 1993, Dementia.

[46]  P. Illés,et al.  Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with mu-opioid receptors. , 1993, European journal of pharmacology.

[47]  K. Fuxe,et al.  Evidence for specific N-terminal galanin fragment binding sites in the rat brain. , 1992, European journal of pharmacology.

[48]  T. Hökfelt,et al.  Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Beal,et al.  Galanin immunoreactivity is increased in the nucleus basalis of meynert in Alzheimer's disease , 1990, Annals of neurology.

[50]  T. Hökfelt,et al.  Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin , 1989, Neuroscience.

[51]  P. Verbanck,et al.  Galanin decreases the activity of locus coeruleus neurons in vitro. , 1989, European journal of pharmacology.

[52]  V. Chan‐Palay.  Galanin hyperinnervates surviving neurons of the human basal nucleus of meynert in dementias of alzheimer's and parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia , 1988, The Journal of comparative neurology.

[53]  T. Hökfelt,et al.  Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. , 1988, Journal of chemical neuroanatomy.

[54]  T. Hökfelt,et al.  Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy , 1987, Neuroscience Letters.

[55]  D. Jacobowitz,et al.  Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system , 1986, Peptides.

[56]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[57]  T. Hökfelt,et al.  A galanin-like peptide in the central nervous system and intestine of the rat , 1984, Neuroscience Letters.

[58]  Hans Jörnvall,et al.  Galanin — a novel biologically active peptide from porcine intestine , 1983, FEBS letters.

[59]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.